X-108170621-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033641.4(COL4A6):āc.3481A>Gā(p.Ile1161Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0542 in 1,201,111 control chromosomes in the GnomAD database, including 1,369 homozygotes. There are 20,788 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_033641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A6 | NM_033641.4 | c.3481A>G | p.Ile1161Val | missense_variant | 35/45 | ENST00000334504.12 | NP_378667.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A6 | ENST00000334504.12 | c.3481A>G | p.Ile1161Val | missense_variant | 35/45 | 5 | NM_033641.4 | ENSP00000334733.7 |
Frequencies
GnomAD3 genomes AF: 0.0388 AC: 4345AN: 112011Hom.: 74 Cov.: 23 AF XY: 0.0355 AC XY: 1213AN XY: 34179
GnomAD3 exomes AF: 0.0405 AC: 7050AN: 174213Hom.: 123 AF XY: 0.0409 AC XY: 2500AN XY: 61111
GnomAD4 exome AF: 0.0558 AC: 60752AN: 1089045Hom.: 1295 Cov.: 30 AF XY: 0.0549 AC XY: 19574AN XY: 356793
GnomAD4 genome AF: 0.0388 AC: 4346AN: 112066Hom.: 74 Cov.: 23 AF XY: 0.0355 AC XY: 1214AN XY: 34244
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 27, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Hearing loss, X-linked 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at